TAC Asks Supreme Court of Appeal to Consider Public Health in Patent Dispute Over Cancer Medicine

Submitted by AA South Africa on Fri, 20/04/2012 - 13:13

[Treatment Action Campaign]

The TAC National Council has resolved to seek admission in a legal dispute between the brand name drug company Aventis Pharma and the generic company Cipla, over a claim of patent infringement on a drug that treats cancer called Docetaxel. SECTION27 will act as attorneys for TAC.